Navigation Links
MRI finds breast cancer before it becomes dangerous
Date:8/13/2007

A study in the Lancet (vol. 370, 11 August 2007) could lead to a change of paradigm in the early diagnosis of breast cancer. It states that magnetic resonance imaging (MRI) is substantially more accurate than mammography in diagnosing very early stages of breast cancer . Up to now MRI was thought to be hardly suited for the detection of such 'ductal carcinoma in situ (DCIS) . Researchers at the University of Bonn have now come to a completely different conclusion. In the past five years they examined more than 7000 women with both methods. In a total of 167 women the doctors found early forms of breast cancer 152 (92 %) of these were found using MRT, 93 (56 %) with mammography.

Breast cancer forms in the cells which line the inside walls of the milk ducts. The tumour initially remains in the milk duct and is therefor called " intraductal cancer" or DCIS (ductal carcinoma in situ). Although even at this stage it is called a carcinoma, it behaves actually like a benign disease, which can always be treated successfully by operating on it. Only when the tumour grows out of the milk ducts into the breasts glandular tissue can it spread via blood and lymph vessels in the body. 'If we find DCIS and remove it we can prevent the formation of real breast cancer,' the Bonn radiologist Professor Christiane Kuhl explains. 'That way we prevent the development of a disease that is often life-threatening.'

However, there are different forms of intraductal carcinomas: the less aggressive (low-grade) and highly aggressive (high-grade) DCIS. Whereas low-grade DCIS is relatively inert and may never spread beyond the milk duct (and thus may never pose a threat to the women affected), high-grade DCIS will virtually always break out of the milk ducts, and then will become dangerous, biologically aggressive high grade invasive breast cancer. This makes it all the more important to discover such high-grade DCIS.

Until To date mammography was the 'gold standard' of breast cancer medicine

It has been known for a long time that MRI is superior to mammography as far as the diagnosis of invasive breast cancer is concerned. However, the search for DCIS to date has been the preserve of mammography. It highlights small calcifications which form in the milk ducts affected. On the MRI scan, depositions of this kind are invisible. Therefore MRI was hitherto seen as unsuited for detecting intraductal carcinoma, which was one of the main reasons for only using mammography for the early detection of breast cancer.

With their results the Bonn researchers confounded this textbook wisdom. A total of 7319 women were investigated by Professor Kuhl and her colleagues in the last five years using both methods. In 167 of them they found early stages of breast cancer. 'Using mammography only 93 cases of DCIS could be seen, compared with 153 cases detected by MRT,' is how Professor Kuhl sums up the results. 'And not only that: it was above all the particularly aggressive high-grade DCIS which were especially reliably picked up using MRI, but especially difficult to detect using mammography.'

A total of 89 cases of high-grade DCIS were discovered by the doctors in the course of the study. MRI, detected 98 per cent of these aggressive pre-invasive breast cancers , with mammography only detecting 52 per cent. The reason for this was that as it appears, in particular the fast growing tumours do not develop the calcifications which constitute the basis of mammographic DCIS diagnosis. Instead, these DCIS are pervaded by many small blood vessels in which the contrast medium that is injected for an MRT scan collects particularly well.

Professor Kuhl concludes from this that Our study demolishes a whole series of textbook dogmas. Firstly, it was always said that MRT was not able to find early stages of breast cancer in the milk ducts. As our results show, the opposite is true. MRT is far more sensitive than mammography.' The second prejudice is that MRT often leads to 'false positives', i.e. often causes 'false alarms'. 'Among our patients that was even less the case with MRI than with mammography,' Professor Kuhl emphasises. 'The positive predictive value of MRT was 59 per cent, compared to 55 per cent for mammography.' The third point was that until now it was assumed that MRI was only necessary for early detection of breast cancer in women with an increased risk of breast cancer. Yet many of the participants had taken part in the study as part of the perfectly normal cancer check-up. The conclusion of the Bonn research team is that MRI can improve the diagnosis of very early stages of breast cancer significantly, not simply with high-risk groups, but with all women.

Expertise needed

However, Professor Kuhl does not want the Bonn results to be used as an argument against current mammography screening programmes. 'Mammography is a basic examination that is essential for early detection.' MRI is not yet ready for use as a mass screening tool. 'Too little use is made of the method in the field of breast imaging, so correspondingly there are too few radiologists who have been able to gain sufficient experience with this specific application,' she says. In order to evaluate the MRI scans, an experienced eye is needed. It is the radiologist that diagnoses the patient, not the magnet. In order to find these pre-invasive stages of breast cancer on an MRI scan, the images need to be evaluated according to specific criteria. Unfortunately awareness of this is not yet sufficiently widespread.


'/>"/>

Contact: Professor Christiane Kuhl
kuhl@uni-bonn.de
49-022-828-719-875
University of Bonn
Source:Eurekalert

Related medicine news :

1. Over Six Million HIV Infected People In South Africa- Finds A Survey
2. Its Never Too Late to Stop Smoking,Study Finds
3. Research finds new explanations for dyslexia
4. Poll Finds Many Americans Misinformed About Cancer
5. Poll Finds Many Americans Misinformed About Cancer
6. Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories
7. Study Finds No Link Between Statins And Breast Cancer Risk
8. Survey finds that discussion with family very crucial in organ donation decision
9. Study finds no link between fibre and cancer risk
10. Study Finds Low Socio-Economic Status Linked to Poor Dental Health
11. Australian Court Finds Man Guilty of Spreading HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now ... country. The AutismOne 2016 Conference, which is being held May 25-29 at the Loews ... elsewhere about helpful interventions and causes of chronic illness in children. , Very recent ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - ... Medical Devices sector report, "Aesthetic Devices - Medical Devices ... currently in pipeline stage. This report ... and primary research by GlobalData,s team of industry experts. ... removed or altered based on the availability and relevance ...
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016  Neurocrine ... the Company will report its fourth quarter and year-end ...  February 11, 2016.  Neurocrine will then host a live ... and provide a Company update Thursday afternoon, February 11, ... Time). http://www.neurocrine.com . --> http://www.neurocrine.com ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016   GS1 ... healthcare professionals to guide them through GS1 Standards implementation ... Drug Administration (FDA) Unique Device Identification (UDI) rule. ... GS1 US; Beth Gibson , senior director industry ... , industry development director, GS1 US --> ...
Breaking Medicine Technology: